Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Antigen delivery format variation and formulation stability through use of a hybrid vector.

Beitelshees M, Hill A, Li Y, Chen M, Ahmadi MK, Smith RJ Jr, Andreadis ST, Rostami P, Jones CH, Pfeifer BA.

Vaccine X. 2019 Jan 30;1:100012. doi: 10.1016/j.jvacx.2019.100012. eCollection 2019 Apr 11.

2.

Atolypenes, Tricyclic Bacterial Sesterterpenes Discovered Using a Multiplexed In Vitro Cas9-TAR Gene Cluster Refactoring Approach.

Kim SH, Lu W, Ahmadi MK, Montiel D, Ternei MA, Brady SF.

ACS Synth Biol. 2019 Jan 18;8(1):109-118. doi: 10.1021/acssynbio.8b00361. Epub 2018 Dec 21.

3.

Increased production of yersiniabactin and an anthranilate analog through media optimization.

Moscatello N, Qi R, Ahmadi MK, Pfeifer BA.

Biotechnol Prog. 2017 Sep;33(5):1193-1200. doi: 10.1002/btpr.2496. Epub 2017 Jun 12.

PMID:
28547883
4.

Improved heterologous production of the nonribosomal peptide-polyketide siderophore yersiniabactin through metabolic engineering and induction optimization.

Ahmadi MK, Pfeifer BA.

Biotechnol Prog. 2016 Nov;32(6):1412-1417. doi: 10.1002/btpr.2369. Epub 2016 Oct 28.

PMID:
27681485
5.

E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent.

Ahmadi MK, Fang L, Moscatello N, Pfeifer BA.

Metab Eng. 2016 Nov;38:382-388. doi: 10.1016/j.ymben.2016.10.001. Epub 2016 Oct 5.

PMID:
27718358
6.

In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.

Li Y, Beitelshees M, Fang L, Hill A, Ahmadi MK, Chen M, Davidson BA, Knight P 3rd, Smith RJ Jr, Andreadis ST, Hakansson AP, Jones CH, Pfeifer BA.

Sci Adv. 2016 Jul 1;2(7):e1600264. doi: 10.1126/sciadv.1600264. eCollection 2016 Jul.

7.

Recent progress in therapeutic natural product biosynthesis using Escherichia coli.

Ahmadi MK, Pfeifer BA.

Curr Opin Biotechnol. 2016 Dec;42:7-12. doi: 10.1016/j.copbio.2016.02.010. Epub 2016 Mar 1. Review.

PMID:
26942861
8.

Molecular variation of the nonribosomal peptide-polyketide siderophore yersiniabactin through biosynthetic and metabolic engineering.

Ahmadi MK, Fawaz S, Fang L, Yu Z, Pfeifer BA.

Biotechnol Bioeng. 2016 May;113(5):1067-74. doi: 10.1002/bit.25872. Epub 2015 Nov 20.

PMID:
26524346
9.

Total Biosynthesis and Diverse Applications of the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin.

Ahmadi MK, Fawaz S, Jones CH, Zhang G, Pfeifer BA.

Appl Environ Microbiol. 2015 Aug 15;81(16):5290-8. doi: 10.1128/AEM.01373-15. Epub 2015 May 29.

10.

Segmental ATN in a kidney with a single artery transplanted from living related donor.

Uğur O, Caner B, Bakkaloğlu M, Ergün EL, Toklu C, Ahmadi MK, Bekdik C.

Nuklearmedizin. 1996 Oct;35(5):190-2.

PMID:
8933528

Supplemental Content

Loading ...
Support Center